Newsletters
DTN 169: A cell built from scratch grows and divides
Plus: Supersonic flight returns to the US, Realta Fusion generates electricity, Anthropic to begin developing drugs of its own, the White House goes all in on UAPs, and more.
Newsletters
Plus: Supersonic flight returns to the US, Realta Fusion generates electricity, Anthropic to begin developing drugs of its own, the White House goes all in on UAPs, and more.
Conversations
Adam Draper is the founder and managing director of Boost VC, a pre-seed venture capital firm that writes first checks for deep tech startups across crypto, space, biotech, robotics, and AI.
Newsletters
Plus: Colossal's endangered species biovault, Chinese supercomputer passes US for fastest in the world, the first nuclear clocks, electronics can now be printed on to living tissue, and more.
Conversations
René Kromhof is a founding partner at Cloudberry VC, Europe's first venture capital firm dedicated to semiconductors, photonics, and advanced materials.
Newsletters
Plus: Valar Atomics goes critical, US battery manufacturing breaks records, first therapy to make cells young again given to a human, autonomous labs are running 24/7, missile production's motor bottleneck, quantum hyperdimensional computing, and more.
Conversations
Will Edwards is the co-founder and CEO of Firehawk Aerospace, a defense technology company that uses 3D printing to mass-produce rocket propellant, solid rocket motors, and full rocket systems.
Newsletters
Plus: Avalanche's desktop fusion reactor, NASA's X-59 goes supersonic, NY lawmakers pass first in US data center moratorium, China's big bet on big nuclear reactors, and more.
The most widely read newsletter in deep tech. Get exclusive interviews, deals, and news from the frontier in your inbox. Every Friday.
Viktor Shpakovsky is an investment partner at Beyond Earth Ventures, a $30 million venture capital fund investing in transformative deep tech across space tech, robotics, energy, and compute.
Plus: Agtech investment is booming, SpaceX outlines plans for Starfall re-entry vehicles, AI executives call for stricter regulations on synthetic biology, the people who want AI to replace humanity, and more.
Brian Wilcove is the managing director of America's Frontier Fund (AFF), a sovereign-aligned venture capital firm investing in frontier technologies to strengthen U.S. innovation and economic competitiveness.
Plus: Blue Origin's mega-rocket explodes, race to mine the deep sea, IBM's first pure-play quantum chip foundry, NASA selects companies for moon base awards, and more.
Plus: Biomanufacturing to reshape organ transplants, grid batteries are booming, quantum's make-or-break moment, growing chickens in 3D printed eggs, Japan sells out of robot wolves, in-space refueling demo, and more.
Plus: Helium-3 lunar gold rush, Virgin Galactic to begin commercial service, Cowboy files for 20k orbital data centers, non-viral gene therapy, real life gundams, and more.
Plus: China opens rocket launches to international satellites, the future of IVF, a geothermal IPO, big tech targets drug discovery, DARPA eyes commercial space boom, and more.
Plus: Pentagon's drone spending spree, air taxis come to NYC, Zuck's virtual biology initiative, DeepSeek's new model, FDA wants to accelerate clinical trails with AI, and more.
Plus: New Glenn suffers upper stage malfunction, China ramps up satellite capacity, cracks in fusion's funding boom, robot marathon, slime-like artificial muscles, cocaine-fueled salmon, and more.
Paul Veugen is co-founder and partner at NP-Hard Ventures, an Amsterdam-based early-stage venture capital firm investing in pre-seed and seed companies solving the hardest problems across robotics, defense tech, and foundational infrastructure.
Plus: nuclear reactors on the moon, implantable pharmacies, 3D printing batteries, first complete human genome loaded onto quantum computer, Science Corp gets ready for brain implant, ARPA-E doubles down on fusion, and more.
Nirmesh Patel is an investor at Amino Collective, an early-stage health and bio fund investing at the intersection of AI and the life sciences.